ATOS

Atossa Therapeutics, Inc.

Contracts

Total Value

Stock Metrics

8.9%

Short % Float

13.5d to cover · Moderate squeeze

17.4%

Inst % Float

10 holders · 2026-06-30

Vanguard Capital M

Top Holder

3.6% of float

8.6M sh

Public Float

44/100

Dilution Score

Medium

14 mo

Cash Runway

Verified regulatory filings & proprietary analysis.

Dilution Risk

44/100

MEDIUM

Inst: 17.39% · Top: Vanguard Capital Management LLC

Biotech Analytics

Biotech / Pharma

15.62

Score drop -10ptsSqueeze risk: MODERATEBiotech Grade: F

Insider Buying0

Publications100

Dilution Risk44

Clinical Trials12

Short Interest30